Literature DB >> 6639410

Papilledema in the metastatic jugular foramen syndrome.

F Graus, N E Slatkin.   

Abstract

In a patient with Ewing's tumor, bilateral papilledema developed along with a left jugular foramen syndrome. Plain tomograms demonstrated a metastasis at the base of the skull. A digital intravenous angiogram showed an occlusion of the left transverse sinus at the level of the jugular foramen. The papilledema was explained by an increase in the intracranial pressure due to the rapid obstruction of venous drainage by the metastasis.

Entities:  

Mesh:

Year:  1983        PMID: 6639410     DOI: 10.1001/archneur.1983.04050120066010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

Review 1.  Skull-base metastases.

Authors:  Florence Laigle-Donadey; Sophie Taillibert; Nadine Martin-Duverneuil; Jerzy Hildebrand; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

2.  Partial, non-thrombotic, superior sagittal sinus occlusion due to occipital skull tumours.

Authors:  G T Plant; J J Donald; A Jackowski; S J Vinnicombe; B E Kendall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

Review 3.  Monro-Kellie 2.0: The dynamic vascular and venous pathophysiological components of intracranial pressure.

Authors:  Mark H Wilson
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-12       Impact factor: 6.200

4.  Jugular foramen syndrome as initial presentation of metastatic lung cancer.

Authors:  Dustin Hayward; Christopher Morgan; Bahman Emami; Jose Biller; Vikram C Prabhu
Journal:  J Neurol Surg Rep       Date:  2012-02-17

5.  Glossopharyngeal and Hypoglossal Nerve Paralysis Secondary to Prevertebral Phlegmon.

Authors:  Ryunosuke Fukushi; Izaya Ogon; Yoshinori Terashima; Hiroyuki Takashima; Tsutomu Oshigiri; Noriyuki Iesato; Mitsunori Yoshimoto; Makoto Emori; Atsushi Teramoto; Toshihiko Yamashita
Journal:  Case Rep Orthop       Date:  2020-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.